Blockchain-based solution for COVID-19 vaccine waste reduction.
J Clean Prod
; 372: 133619, 2022 Oct 20.
Article
in English
| MEDLINE | ID: covidwho-1996321
ABSTRACT
Coronavirus 2019 (COVID-19) vaccines have been produced on a large scale since 2020. However, large-scale vaccine production has led to two forms of waste; namely, overproduction and underutilization. Most of today's systems and technologies used to manage waste data related to COVID-19 vaccines fall short of providing transparency, traceability, accountability, trust, and security features. In this paper, we address the problem of COVID-19 vaccines waste due to their overproduction and underutilization. We propose a blockchain-based solution that is composed of five phases registration, commitment; production and delivery; consumption; and waste assessment. These phases make up the complete life cycle of a COVID-19 vaccine, and they are governed by several smart contracts to ensure accountability of all the actions taken by the involved entities and reduce any excessive waste caused by overproduction, overordering, or underconsumption. We ensure security, traceability, and data provenance by recording all actions through smart contracts in the form of events on an immutable ledger. We utilize decentralized storage such as the InterPlanetary File System (IPFS) to reduce the costs posed by large-sized file storage when stored on-chain. We present algorithms that describe the logic behind our developed smart contracts. We test and validate the functionalities of our proposed solution. We conduct security, cost, and scalability analyses to show that our solution is affordable, scalable, and secure. We compare our solution with the existing blockchain-based solutions to show its novelty and superiority. The smart contract code is made publicly available on GitHub.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
J Clean Prod
Year:
2022
Document Type:
Article
Affiliation country:
J.jclepro.2022.133619
Similar
MEDLINE
...
LILACS
LIS